Published in Cardiovascular Business Week, October 11th, 2005
Additionally, the board approved a $15 million contribution to The Edwards Lifesciences Fund, a charitable fund.
"The new share repurchase program demonstrates our confidence in Edwards' future and enables us to offset the dilution of shares issued under our employee ownership programs," said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.